We are live on
!
Find out more
SELLAS Life Sciences
20 hedge funds and large institutions have $5.1M invested in SELLAS Life Sciences in 2018 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
4,050% more call options, than puts
Call options by funds: $166K | Put options by funds: $4K
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
100% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 5
62% more capital invested
Capital invested by funds: $3.16M → $5.1M (+$1.95M)
33% more funds holding
Funds holding: 15 → 20 (+5)
0.11% more ownership
Funds ownership: 0.26% → 0.38% (+0.11%)
Holders
20
Holders Change
+5
Holders Change %
+33.33%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
6
Reduced
1
Closed
5
Calls
$166K
Puts
$4K
Net Calls
+$162K
Net Calls Change
+$2K
Top Buyers
| 1 |
6CM
683 Capital Management
New York
|
+$968K |
| 2 |
Renaissance Technologies
New York
|
+$689K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$401K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$177K |
| 5 |
BlackRock
New York
|
+$162K |
